HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

ICER Releases Final Report and Policy Recommendations for Ulcerative Colitis Treatments

The Institute for Clinical and Economic Review (ICER) recently released a Final Evidence Report and Report-at-a-Glance evaluating comparative clinical effectiveness and value of the following targeted immune modulators (TIMs) for moderate-to-severe ulcerative colitis:     […]

more info 10/19/2020View Related Articles
Bookmark and Share

Reminder: ICER Webinar on Cost-Recovery Pricing for COVID-19 Drugs is Tomorrow

The first installment of the Institute for Clinical and Economic Review's (ICER) three-part webinar series on drug pricing models for COVID-19 treatments is tomorrow, July 24. Set to begin at noon, the webinar will explore cost-recovery pricing, a model used to cover costs associated with […]

more info 07/23/2020View Related Articles
Bookmark and Share

First Installment in ICER Webinar Series is Friday

The first session of the Institute for Clinical and Economic Review's (ICER) upcoming webinar series is set for Friday, July 24. ICER is hosting a 3-part colloquium series to complement its recent white paper on alternative approaches for pricing COVID-19 treatments and vaccines. The first […]

more info 07/20/2020View Related Articles
Bookmark and Share

ICER Hosting Series on Drug Pricing During a Pandemic

The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during a pandemic. The first session, which will discuss cost-recovery pricing, is set for noon EST July 24. Confirmed speakers include: Afton Cissell, JD, Senior Counsel […]

more info 07/13/2020View Related Articles
Bookmark and Share

ICER Reschedules CF Meeting

The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. According to a press release, the meeting, which had originally been postponed due to the COVID-19 pandemic, will take place online. To read the full press […]

more info 07/09/2020View Related Articles
Bookmark and Share

ICER Outlines Planned Review of High Cholesterol Treatments

The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. ICER's assessment will include Novartis' inclisiran, Esperion Therepeutics' Nexletol and Nexlizet, according to a press release. Comments on the […]

more info 07/07/2020View Related Articles
Bookmark and Share

ICER Posts White Paper on Alternative Pricing Policies During Pandemic

The Institute for Clinical and Economic Review (ICER) announced the release of a new white paper on alternative policies for pricing drugs and vaccines during a pandemic. ICER is also set to host a three-part online series in which experts will discuss the advantages and disadvantages of […]

more info 07/02/2020View Related Articles
Bookmark and Share

ICER Cancels Meeting for Non-Alcoholic Steatohepatitis Assessment

The Institute for Clinical and Economic Review (ICER) has canceled the August meeting of the Midwest CEPAC. The meeting was set to discuss the effectiveness and value of obeticholic acid for the treatment of non-alcoholic steatohepatitis. "This decision is the result of the Food and Drug […]

more info 07/02/2020View Related Articles
Bookmark and Share

Reminder: ICER Accepting Comments on Annual Unsupported Price Increase Assessment

The Institute for Clinical and Economic Review (ICER) is accepting public input on the target drugs for this year's Unsupported Price Increase Assessment. Public feedback will be accepted until July 17. According to ICER, the final report is slated to be posted on Jan. 8, 2021. To read the […]

more info 06/30/2020View Related Articles
Bookmark and Share

ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease

The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in chronic kidney disease. An open input period will remain open until 5 p.m. EST July 15. According to a press release, a document outlining the planned review […]

more info 06/26/2020View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • SQL Developer
  • Senior Research Consultant - Modelling and Meta Analysis
  • Research Consultant - Evidence Synthesis & Economic Modelling
  • Associate Director – Modelling & Meta-Analysis
  • Director, Real World Evidence
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists